The AstraZeneca Case and Why Women Still Make Less Than Men

The women of AstraZeneca have struck one for equal pay. The London-based drug behemoth, which produces medicines for a range of cardiovascular, respiratory and other conditions including various cancers, agreed on June 6 to pay $250,000 to 124 of its U.S. female sales workers. The deal wraps up a Department of Labor lawsuit in which the Philadelphia-based women claimed they were making on average $1,700 less than their male counterparts.